Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Dec 08
 -3.92 / -1.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 394.00, with a high estimate of 456.00 and a low estimate of 325.00. The median estimate represents a +12.56% increase from the last price of 350.03.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jan 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.90%
Growthannually -2.24%


Growthquarterly 1.00%
Growthannually 9.44%
Key to the earnings and sales forecast charts.